Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Tibor van Welsem
Affiliation
Netherlands Cancer Institute
ORCID
Career Start Year
2000
Papers
30
H Index
18
Expertise
CM4AI Collaborator
Trey Ideker (CM4AI)
PMID
Paper Title
Journal Title
Published Year
37995691
Locus-specific proteome decoding reveals Fpt1 as a chromatin-associated negative regulator of RNA polymerase III assembly.
Mol Cell
2023
36052643
The histone methyltransferase SETD2 negatively regulates cell size.
J Cell Sci
2022
36425063
DOT1L inhibition does not modify the sensitivity of cutaneous T cell lymphoma to pan-HDAC inhibitors <i>in vitro</i>.
Front Genet
2022
32299836
A genetic interaction map centered on cohesin reveals auxiliary factors involved in sister chromatid cohesion in <i>S. cerevisiae</i>.
J Cell Sci
2020
32764145
The histone methyltransferase DOT1L prevents antigen-independent differentiation and safeguards epigenetic identity of CD8<sup>+</sup> T cells.
Proc Natl Acad Sci U S A
2020
32188699
Inhibition of transcription leads to rewiring of locus-specific chromatin proteomes.
Genome Res
2020
32154221
Strategy for Development of Site-Specific Ubiquitin Antibodies.
Front Chem
2020
31304633
Conserved crosstalk between histone deacetylation and H3K79 methylation generates DOT1L-dose dependency in HDAC1-deficient thymic lymphoma.
EMBO J
2019
30005073
Decoding the chromatin proteome of a single genomic locus by DNA sequencing.
PLoS Biol
2018
30203048
Dot1 promotes H2B ubiquitination by a methyltransferase-independent mechanism.
Nucleic Acids Res
2018
28291796
The effect of acetaminophen on ubiquitin homeostasis in Saccharomyces cerevisiae.
PLoS One
2017
27922451
Direct screening for chromatin status on DNA barcodes in yeast delineates the regulome of H3K79 methylation by Dot1.
Elife
2016
25965993
Dot1 histone methyltransferases share a distributive mechanism but have highly diverged catalytic properties.
Sci Rep
2015
25141862
Flexibility in crosstalk between H2B ubiquitination and H3 methylation in vivo.
EMBO Rep
2014
23438860
A network model of the molecular organization of chromatin in Drosophila.
Mol Cell
2013
24360959
A UV-induced genetic network links the RSC complex to nucleotide excision repair and shows dose-dependent rewiring.
Cell Rep
2013
23708297
Recombination-induced tag exchange (RITE) cassette series to monitor protein dynamics in Saccharomyces cerevisiae.
G3 (Bethesda)
2013
22807688
A key role for Chd1 in histone H3 dynamics at the 3' ends of long genes in yeast.
PLoS Genet
2012
21291527
Dot1 binding induces chromatin rearrangements by histone methylation-dependent and -independent mechanisms.
Epigenetics Chromatin
2011
21998594
A barcode screen for epigenetic regulators reveals a role for the NuB4/HAT-B histone acetyltransferase complex in histone turnover.
PLoS Genet
2011
21760613
Progressive methylation of ageing histones by Dot1 functions as a timer.
EMBO Rep
2011
21666805
Patterns and mechanisms of ancestral histone protein inheritance in budding yeast.
PLoS Biol
2011
20018668
Recombination-induced tag exchange to track old and new proteins.
Proc Natl Acad Sci U S A
2010
21084562
Heterologous expression reveals distinct enzymatic activities of two DOT1 histone methyltransferases of Trypanosoma brucei.
J Cell Sci
2010
18391024
Synthetic lethal screens identify gene silencing processes in yeast and implicate the acetylated amino terminus of Sir3 in recognition of the nucleosome core.
Mol Cell Biol
2008
18511943
Nonprocessive methylation by Dot1 leads to functional redundancy of histone H3K79 methylation states.
Nat Struct Mol Biol
2008
15705879
Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations.
Cancer Res
2005
12670888
Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method.
Cancer Res
2003
12460933
Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors.
Cancer Res
2002
11062467
Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.
Nat Genet
2000
1 - 30 of 30
Column Actions
Search
Recommended Authors
Maria J Aristizabal
Queen's University
Career Start Year
2011
Number of shared co-authors
1
Scott B Rothbart
Van Andel Institute
Career Start Year
2009
Number of shared co-authors
0
Raghuvar Dronamraju
University of North Carolina at Chapel Hill School of Medicine
Career Start Year
2009
Number of shared co-authors
0
J Peter Svensson
Karolinska Institutet
Career Start Year
2005
Number of shared co-authors
1
Cheng-Fu Kao
Institute of Cellular and Organismic Biology
Career Start Year
2003
Number of shared co-authors
0
Tiaojiang Xiao
National Institute of Diabetes and Digestive and Kidney Diseases
Career Start Year
2002
Number of shared co-authors
0
Ashby J Morrison
Stanford University
Career Start Year
2001
Number of shared co-authors
0
Nicolas Lacoste
Institut NeuroMyoGene, Universite Lyon1-CNRS UMR1-INSERM U1315
Career Start Year
2001
Number of shared co-authors
0
Erin M Green
University of Maryland Baltimore County
Career Start Year
2001
Number of shared co-authors
1
Assen Roguev
University of California, USA Quantitative Biosciences Institute (QBI) san francisco
Career Start Year
2000
Number of shared co-authors
2
Sigurd Braun
Biomedical Center, Ludwig-Maximilians-Universitat of Munich
Career Start Year
2000
Number of shared co-authors
0
Nevan J Krogan (CM4AI)
University of California San Francisco
Career Start Year
1998
Number of shared co-authors
11
Siavash K Kurdistani
David Geffen School of Medicine, University of California los angeles
Career Start Year
1998
Number of shared co-authors
1
Michael-Christopher Keogh
EpiCypher Inc.
Career Start Year
1997
Number of shared co-authors
5
Zhiguo Zhang
Institute for Cancer Genetics, Columbia University Irving Medical Center
Career Start Year
1997
Number of shared co-authors
0
Jason D Lieb
The University of Chicago
Career Start Year
1996
Number of shared co-authors
1
Brian D Strahl
University of North Carolina
Career Start Year
1996
Number of shared co-authors
1
Fran??ois Robert
Institut de recherches cliniques de Montreal
Career Start Year
1996
Number of shared co-authors
1
Colin Logie
Radboud Institute for Molecular Science, Radboud University
Career Start Year
1995
Number of shared co-authors
0
Zu-Wen Sun
EpiCypher Inc.
Career Start Year
1995
Number of shared co-authors
0
Bradley E Bernstein
Broad Institute of MIT and Harvard
Career Start Year
1994
Number of shared co-authors
0
Or Gozani
Stanford University
Career Start Year
1994
Number of shared co-authors
0
Scott D Briggs
Purdue University
Career Start Year
1993
Number of shared co-authors
0
Ali Shilatifard
Northwestern University Feinberg School of Medicine
Career Start Year
1991
Number of shared co-authors
1
Karl Ekwall
Karolinska Institute
Career Start Year
1991
Number of shared co-authors
2
Jacques C??t??
Centre Hospitalier Universitaire (CHU) de Quebec-Universite Laval Research Center
Career Start Year
1987
Number of shared co-authors
2
Shelley L Berger
Penn Epigenetics Institute, Perelman School of Medicine
Career Start Year
1985
Number of shared co-authors
0
Lorraine Pillus
University of California San Diego
Career Start Year
1980
Number of shared co-authors
3
Steven Henikoff
Fred Hutchinson Cancer Center
Career Start Year
1974
Number of shared co-authors
1
C David Allis
The Rockefeller University
Career Start Year
1974
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Fred van Leeuwen
Netherlands Cancer Institute, University of Amsterdam
Co-authored papers
26
Hanneke Vlaming
Blavatnik Institute, Harvard Medical School
Co-authored papers
7
Tessy Korthout
Oncode Institute
Co-authored papers
6
Huib Ovaa
Leiden University Medical Center
Co-authored papers
4
Thom M Molenaar
Amsterdam UMC location Vrije Universiteit Amsterdam
Co-authored papers
4
Tineke L Lenstra
the Netherlands Cancer Institute, Oncode Institute
Co-authored papers
4
Deepani W Poramba-Liyanage
Utrecht University Utrecht The Netherlands.
Co-authored papers
4
Iris J E Stulemeijer
Netherlands Cancer Institute
Co-authored papers
4
Albert J R Heck
Utrecht University
Co-authored papers
3
Trey Ideker (CM4AI)
University of California San Diego
Co-authored papers
3
Frank C P Holstege
Princess Maxima Center for Pediatric Oncology
Co-authored papers
3
Laura J Van't Veer
University of California San Francisco
Co-authored papers
3
Haico van Attikum
Leiden University Medical Center
Co-authored papers
3
Rohith Srivas
Amgen Inc.
Co-authored papers
2
Su Ming Sun
Leiden University Medical Center
Co-authored papers
2
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Co-authored papers
2
Oliver J Rando
University of Massachusetts Chan Medical School
Co-authored papers
2
Farid El Oualid
The Netherlands Cancer Institute
Co-authored papers
2
Kirsten van Harten
Netherlands Cancer Institute
Co-authored papers
2
Bas van Steensel
Oncode Institute, Netherlands Cancer Institute
Co-authored papers
1
Sovan Sarkar
CRUK MRC Oxford Institute for Radiation Oncology, University of Oxford
Co-authored papers
1
Marijke Pool
Leiden University Medical Center
Co-authored papers
1
Katherine Licon
University of California San Diego
Co-authored papers
1
Amandine Batt??
Center for Integrative Genomics, University of Lausanne
Co-authored papers
1
Su Ming Sun
Leiden University Medical Center
Co-authored papers
1
Erik Malta
Leiden University Medical Center
Co-authored papers
1
Peter J McHugh
MRC Weatherall Institute of Molecular Medicine, University of Oxford
Co-authored papers
1
George Q Daley
Boston Children's Hospital, Harvard Medical School
Co-authored papers
1
Susan M Gasser
L'Institut Suisse de Recherche Experimentale sur le Cancer (ISREC) Foundation
Co-authored papers
1
Sophie C van der Horst
Leiden University Medical Center
Co-authored papers
1
1 - 30